← FDA DRUG APPROVALS

FDA ANDA · ANDA090370

VALACYCLOVIR HYDROCHLORIDE

Sponsor: WATSON LABS INC

APPLICATION
ANDA090370
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-16
LATEST ACTION
2020-03-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VALACYCLOVIR HYDROCHLORIDEDiscontinued
VALACYCLOVIR HYDROCHLORIDE EQ 1GM BASE · TABLET · ORAL
VALACYCLOVIR HYDROCHLORIDEDiscontinued
VALACYCLOVIR HYDROCHLORIDE EQ 500MG BASE · TABLET · ORAL

Approval history

2020-03-12Labeling · Supplement 9 · standardAP
2011-03-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →